Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07523516 | Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer | not yet recruiting | — | 97 | Assiut UniversityOTHER | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07523607 | FAP PET/CT for Staging Patients With Breast Cancer | not yet recruiting | Phase 2 | 65 | Odense University HospitalOTHER | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07523789 |
| Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC |
| not yet recruiting |
| — |
| 201 |
| The First Affiliated Hospital with Nanjing Medical UniversityOTHER |
| 1 |
| Apr 13, 2026 |
| clinicaltrials |
| NCT07519200 | Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention(SHARE-MC) | not yet recruiting | N/A | 96 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT07509515 | QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC. | not yet recruiting | Phase 2 | 60 | Fudan UniversityOTHER | 0 | Apr 3, 2026 | clinicaltrials |
| NCT07340658 | A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer(SIE-3) | not yet recruiting | Phase 3 | 300 | Rovi Pharmaceuticals LaboratoriesINDUSTRY | 0 | Apr 2, 2026 | clinicaltrials |
| NCT07495358 | Development and Usability Evaluation of a Knowledge Graph-Based Symptom Management System for Patients With Breast Cancer Undergoing Chemotherapy(KG-SMR-BC) | not yet recruiting | N/A | 30 | Capital Medical UniversityOTHER | 0 | Apr 1, 2026 | clinicaltrials |
| NCT07502963 | Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer(PREDU) | not yet recruiting | N/A | 70 | University of Vic - Central University of CataloniaOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07499089 | Together-Breast Cancer Support Platform(Together) | not yet recruiting | — | 24 | Cedars-Sinai Medical CenterOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07499999 | Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer(BabyTEARS) | not yet recruiting | Phase 2 | 140 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07500129 | Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer(ExoTSS-BC) | not yet recruiting | — | 60 | Atlas UniversityOTHER | 0 | Mar 30, 2026 | clinicaltrials |
| NCT06396754 | Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC(AIDOBE) | not yet recruiting | — | 50 | Institute of Cancer Research, United KingdomOTHER | 0 | Mar 27, 2026 | clinicaltrials |
| NCT07497191 | AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer | not yet recruiting | — | 300 | Shengjing HospitalOTHER | 0 | Mar 27, 2026 | clinicaltrials |
| NCT07219797 | Study of Monochromatic X-ray Mammography System | not yet recruiting | N/A | 52 | Imagine Scientific, Inc.INDUSTRY | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07489053 | Optimizing Functional Recovery After Breast Cancer Treatment | not yet recruiting | N/A | 352 | MGH Institute of Health ProfessionsOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07492043 | Breast Tumour Size Measurement by Field Cycling Imaging(BREVIA) | not yet recruiting | — | 12 | University of AberdeenOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07491822 | A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer | not yet recruiting | N/A | 43 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Mar 24, 2026 | clinicaltrials |
| NCT07398118 | CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer.(CRYO-1) | not yet recruiting | N/A | 61 | St. Antonius HospitalOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT06495541 | The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive | not yet recruiting | N/A | 500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07484763 | Predicting Recurrence in HR+/HER2- Early Breast Cancer | not yet recruiting | — | 500 | Shengjing HospitalOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07486687 | Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy(PLANET) | not yet recruiting | Phase 3 | 1,000 | The Netherlands Cancer InstituteOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07483996 | Cryoablation Versus Lumpectomy in Early-Stage Breast Cancer(CRYSTAL) | not yet recruiting | Phase 3 | 938 | Franciscus Gasthuis & Vlietland (Hospital)OTHER | 0 | Mar 19, 2026 | clinicaltrials |
| NCT07478315 | IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life | not yet recruiting | N/A | 50 | Charles LeMoyne HospitalOTHER | 0 | Mar 17, 2026 | clinicaltrials |
| NCT07478705 | Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging(EINSTEIN-TNBC) | not yet recruiting | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 0 | Mar 17, 2026 | clinicaltrials |
| NCT07470203 | Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer | not yet recruiting | — | 42 | Peking University Cancer Hospital & InstituteOTHER | 0 | Mar 13, 2026 | clinicaltrials |
| NCT07466303 | Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer | not yet recruiting | Phase 2 | 84 | Xijing HospitalOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07459738 | A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer | not yet recruiting | Phase 2 | 60 | Shanghai Henlius BiotechINDUSTRY | 0 | Mar 10, 2026 | clinicaltrials |
| NCT07458204 | Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer(EPPIL) | not yet recruiting | Phase 2 | 760 | Institut Jean-GodinotOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT07454668 | Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases | not yet recruiting | Phase 1 | 20 | Baptist Health South FloridaOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07428018 | Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib(VIOLET) | not yet recruiting | Phase 2 | 150 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07446686 | Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer | not yet recruiting | Early Phase 1 | 30 | Guizhou Provincial People's HospitalOTHER | 0 | Mar 3, 2026 | clinicaltrials |
| NCT07441486 | A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer | not yet recruiting | Phase 2 | 50 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Mar 2, 2026 | clinicaltrials |
| NCT07443774 | Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.(AdheRA) | not yet recruiting | — | 81 | University Hospital, GrenobleOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT07434817 | Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment | not yet recruiting | N/A | 200 | University of Colorado, DenverOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07436663 | Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC(SGLT2i/DPPi) | not yet recruiting | Phase 4 | 150 | Tanta UniversityOTHER | 0 | Feb 27, 2026 | clinicaltrials |
| NCT07437326 | Food-related Quality of Life in Patients With Cancer(QVA-Mod) | not yet recruiting | — | 180 | Hospices Civils de LyonOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07425379 | Prehabilitation in Breast Cancer Surgery | not yet recruiting | N/A | 54 | Bakirkoy Dr. Sadi Konuk Research and Training HospitalOTHER_GOV | 1 | Feb 24, 2026 | clinicaltrials |
| NCT07427407 | Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers | not yet recruiting | — | 100 | AURA Health TechnologiesINDUSTRY | 1 | Feb 24, 2026 | clinicaltrials |
| NCT07426510 | IRIS: Risk-Based Imaging After Breast-Conserving Surgery(IRIS) | not yet recruiting | N/A | 2,300 | Umeå UniversityOTHER | 0 | Feb 23, 2026 | clinicaltrials |
| NCT06958224 | Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers(ESCAT) | not yet recruiting | N/A | 360 | University Hospital, LilleOTHER | 0 | Feb 20, 2026 | clinicaltrials |
| NCT07394946 | Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.(NELOPHER) | not yet recruiting | Phase 2 | 126 | Cancer Care Hospital & Research Centre Foundation, LahoreOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT07423117 | A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy | not yet recruiting | Phase 1 | 102 | IntoCell, IncINDUSTRY | 0 | Feb 20, 2026 | clinicaltrials |
| NCT07423611 | ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer(RACE) | not yet recruiting | Phase 2 | 388 | Fudan UniversityOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT07197684 | Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery | not yet recruiting | N/A | 120 | Aga Khan UniversityOTHER | 0 | Feb 19, 2026 | clinicaltrials |
| NCT07419711 | Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity | not yet recruiting | N/A | 120 | Nazarbayev UniversityOTHER | 0 | Feb 19, 2026 | clinicaltrials |
| NCT07419867 | A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI | not yet recruiting | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07420335 | Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy | not yet recruiting | N/A | 52 | Indonesia UniversityOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07410559 | Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer | not yet recruiting | Phase 2 | 189 | Fudan UniversityOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07416253 | Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer | not yet recruiting | Phase 2 | 68 | Henan Cancer HospitalOTHER_GOV | 0 | Feb 18, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Apr 13, 2026source: clinicaltrials